Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma
The objective of this research was to develop polymeric micellar formulations of inhibitors of signal transducer and activator of transcription 3 (STAT3) dimerization, i.e., S3I-1757 and S3I-201, and evaluate the activity of successful formulations in B16-F10 melanoma, a STAT3 hyperactive cancer mod...
Gespeichert in:
Veröffentlicht in: | Drug delivery and translational research 2017-08, Vol.7 (4), p.571-581 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The objective of this research was to develop polymeric micellar formulations of inhibitors of signal transducer and activator of transcription 3 (STAT3) dimerization, i.e., S3I-1757 and S3I-201, and evaluate the activity of successful formulations in B16-F10 melanoma, a STAT3 hyperactive cancer model, in vitro and in vivo. STAT3 inhibitory agents were encapsulated in methoxy poly(ethylene oxide)-
b
-poly(ε-caprolactone) (PEO
114
-
b
-PCL
22
) and methoxy poly(ethylene oxide)-
b
-poly(α-benzyl carboxylate-ε-caprolactone) (PEO
114
-
b
-PBCL
20
) micelles using co-solvent evaporation. Polymeric micelles of S3I-1757 showed high encapsulation efficiency (>88%), slow release profile ( |
---|---|
ISSN: | 2190-393X 2190-3948 |
DOI: | 10.1007/s13346-017-0369-4 |